Clinical Trials · NCT00257426
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Enrollment
- 31
- Start date
- Jul 2005
- Locations
- 1 site, United States
- Primary endpoint
- Median survival